clinical trial · NCT05788991
Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis
Medinova AG·phase4·terminated·n = 151
Bacterial VaginosisVaginal InfectionVaginal DiseasesDequalinium ChlorideMetronidazole Oral
brief summary
The goal of this clinical trial is to show the efficacy and safety of dequalinium chloride in the treatment of bacterial vaginosis compared to metronidazole.
started
Jul 26, 2021
primary completion
Aug 25, 2022
completion
Aug 25, 2022
last updated
Oct 16, 2024
detailed description
Eligible patients who signed informed consent were randomized to receive treatment with either dequalinium chloride (+ oral placebo) or metronidazole (+ vaginal placebo) for up to 7 days. Primary objective was clinical cure rate at one week after start of treatment. Control visits to assess outcomes were done after end of treatment and after one month.
official title
Comparative Study of the Efficacy and Safety of Vaginally Applied Dequalinium Chloride (10 mg) and Orally Applied Metronidazole (2 x 500 mg) in the Treatment of Bacterial Vaginosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol